Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03414047
Title A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

peritoneum cancer

fallopian tube cancer

ovarian serous carcinoma

Therapies

Prexasertib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.